Coronavirus updates: In 2020, vaccine maker Novovax Inc had announced a license agreement with the Covishield maker-Serum Institute of India (SII) for the development and commercialisation of its Covid-19 vaccine candidate NVX-CoV2373, or Covovax.
Coronavirus updates: In 2020, vaccine maker Novovax Inc had announced a license agreement with the Covishield maker-Serum Institute of India (SII) for the development and commercialisation of its Covid-19 vaccine candidate NVX-CoV2373, or Covovax.